Cimeio Therapeutics

Cimeio Therapeutics is a company that focuses on developing treatments for genetic diseases, hematologic malignancies, and severe autoimmune disorders. They have developed a technology platform called SCIP that modifies cell surface proteins in HSCs, which could potentially allow more patients to receive a life-saving HSC transplant. Their mission is to improve the eligibility and outcomes of hema...